Advances in Media Formulations for Clinical-Scale Expansion of Cells

In by

Spotlight Article

Interview

Thierry Burnouf

Separation and Expansion Technologies

 

Prof Thierry Burnouf, PhD, is the Vice-Dean of the College of Biomedical Engineering, Director of the Graduate Institute of Biomedical Materials and Tissue Engineering, Director of the International PhD Program in Biomedical Engineering, and Professor in the International PhD Program for Cell Therapy and Regeneration medicine at Taipei Medical University, Taiwan. He has over 30 years of experience in translational research and development and industrial manufacture of human therapeutic plasma proteins (coagulation factors, immunoglobulins, alpha 1-antitrypsin, etc.) and cellular products, with a special interest in protein isolation procedures and virus inactivation and removal technologies. He has been closely involved into the drafting of WHO Guidelines on virus inactivation and removal procedures applied to human blood plasma products, production of animal-derived antivenoms immunoglobulin, and production, quality control and regulation of plasma for fractionation. He is a member of the working parties on Cellular Therapies and Global Blood Safety of the International Society of Blood Transfusion.

DOI: 10.18609/cgti.2018.005
Citation: Cell Gene Therapy Insights 2018; 4(1), 37-43.
Open access

This content is restricted to registered users. Click here to Register or Login here.